Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases

Progress has been made in COVID-19 vaccine development, with encouraging safety and efficacy data. The purpose of this study was to investigate the immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases (AIIRD). Patients with AIIRD (n = 101) were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yi-Qing, Li, He-Jun, Chen, Ling, Lin, Shun-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606114/
https://www.ncbi.nlm.nih.gov/pubmed/36289319
http://dx.doi.org/10.1038/s41598-022-22839-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606114/
https://www.ncbi.nlm.nih.gov/pubmed/36289319
http://dx.doi.org/10.1038/s41598-022-22839-0

Ejemplares similares